Metraipolis › archive › dc_a987f8cb1e09

Medicinal Insights Into FLT3 Inhibitors as Anticancer Agents: Current Status and Future Direction — Europe PMC PMID:42415601

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42415601
DOI
10.1002/ardp.70302
License (as archived)
solo-consultazione
Archived
2026-10-31T23:31:01.639Z
SHA-256 of the archived text
e9b6c4661eefe37b352a13560c180be5639f4ae67ad085de8220ff67c5aa40f8
Stable URL of this page
https://metraipolis.com/documento/dc_a987f8cb1e09

How to cite

Medicinal Insights Into FLT3 Inhibitors as Anticancer Agents: Current Status and Future Direction — Europe PMC PMID:42415601 — Europe PMC (en), https://europepmc.org/article/MED/42415601 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a987f8cb1e09 (Metraipolis archive dc_a987f8cb1e09, sha256 e9b6c4661eefe37b352a13560c180be5639f4ae67ad085de8220ff67c5aa40f8)
BibTeX
@misc{dca987f8cb1e09,
  title = {Medicinal Insights Into FLT3 Inhibitors as Anticancer Agents: Current Status and Future Direction — Europe PMC PMID:42415601},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42415601},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a987f8cb1e09; sha256 e9b6c4661eefe37b352a13560c180be5639f4ae67ad085de8220ff67c5aa40f8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42415601. Agents can read the archived copy with the MCP tool read_document.